Trials / Completed
CompletedNCT00699049
A Study Comparing the Efficacy of an Alpha Blocker Versus an Alpha Blocker Plus Solifenacin in Men With Overactive Bladder
A Randomized, Double Blind, Placebo-Controlled, Parallel Group Comparison of the Efficacy and Safety of Any Alpha Blocker Monotherapy and Any Alpha Blocker Plus Solifenacin in Men With Residual Overactive Bladder Symptoms of Urinary Frequency and Urgency With/Without Urgency Incontinence After Previous Monotherapy With Any Alpha Blocker
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 94 (actual)
- Sponsor
- KYU-SUNG LEE · Academic / Other
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to explore additional benefit of solifenacin after 12-week treatment, compared with alpha blocker monotherapy in men with residual OAB symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alpha blocker | oral |
| DRUG | placebo | oral |
| DRUG | solifenacin | oral |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-06-17
- Last updated
- 2016-01-07
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00699049. Inclusion in this directory is not an endorsement.